Trial · NCT00570739
Adverse events164
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 164
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal distension | Gastrointestinal disorders | Type 2 Diabetes Group: Placebo + Metformin | 5 | 141 | |
| other | Abdominal distension | Gastrointestinal disorders | Type 2 Diabetes Group: Colesevelam + Metformin | 4 | 141 | |
| other | Abdominal distension | Gastrointestinal disorders | Pre-diabetic Group: Placebo | 0 | 108 | |
| other | Abdominal distension | Gastrointestinal disorders | Pre-diabetic Group: Colesevelam | 0 | 107 | |
| other | Abdominal Pain | Gastrointestinal disorders | Type 2 Diabetes Group: Placebo + Metformin | 8 | 141 | |
| other | Abdominal Pain | Gastrointestinal disorders | Type 2 Diabetes Group: Colesevelam + Metformin | 6 | 141 | |
| other | Abdominal Pain | Gastrointestinal disorders | Pre-diabetic Group: Placebo | 3 | 108 | |
| other | Abdominal Pain | Gastrointestinal disorders | Pre-diabetic Group: Colesevelam | 3 | 107 | |
| other | Abdominal pain uppper | Gastrointestinal disorders | Type 2 Diabetes Group: Placebo + Metformin | 3 | 141 | |
| other | Abdominal pain uppper | Gastrointestinal disorders | Type 2 Diabetes Group: Colesevelam + Metformin | 5 | 141 | |
| other | Abdominal pain uppper | Gastrointestinal disorders | Pre-diabetic Group: Placebo | 0 | 108 | |
| other | Abdominal pain uppper | Gastrointestinal disorders | Pre-diabetic Group: Colesevelam | 0 | 107 | |
| other | Constipation | Gastrointestinal disorders | Type 2 Diabetes Group: Placebo + Metformin | 2 | 141 | |
| other | Constipation | Gastrointestinal disorders | Type 2 Diabetes Group: Colesevelam + Metformin | 6 | 141 | |
| other | Constipation | Gastrointestinal disorders | Pre-diabetic Group: Placebo | 5 | 108 | |
| other | Constipation | Gastrointestinal disorders | Pre-diabetic Group: Colesevelam | 10 | 107 | |
| other | Dyspepsia | Gastrointestinal disorders | Type 2 Diabetes Group: Placebo + Metformin | 5 | 141 | |
| other | Dyspepsia | Gastrointestinal disorders | Type 2 Diabetes Group: Colesevelam + Metformin | 5 | 141 | |
| other | Dyspepsia | Gastrointestinal disorders | Pre-diabetic Group: Placebo | 0 | 108 | |
| other | Dyspepsia | Gastrointestinal disorders | Pre-diabetic Group: Colesevelam | 3 | 107 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00570739/events